Accelerated telomere shortening in adrenal zona reticularis in patients with prolonged critical illness.
DHEA
adrenal gland
hypoalbuminemia
prolonged critical illness
telomere
zona reticularis
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
22
06
2023
accepted:
18
08
2023
medline:
26
9
2023
pubmed:
25
9
2023
entrez:
25
9
2023
Statut:
epublish
Résumé
The number of patients with prolonged critical illness (PCI) has been increasing in many countries, and the adrenal gland plays an important role in maintaining homeostasis during PCI. Chronic disease burden is reportedly associated with shorter telomere lengths in human tissues. Telomere shortening in human somatic cells is largely dependent on cell divisions, and critically short telomeres lead to cellular dysfunction and aging. However, the association between PCI and telomere lengths in human adrenal cells is poorly understood. In this study, we investigated this association to assess whether the burden of PCI could accelerate the aging process in adrenal cells. Adrenocortical tissues from patients who died after PCI usually show a diffuse pattern of intracellular cholesterol ester depletion (i.e., lipid depletion). This study examined near-normal adrenal glands obtained from autopsied patients who died suddenly (control group) and lipid-depleted adrenal glands obtained from autopsied patients who died after PCI (PCI group). The control group included 7 men aged 80 to 94 years (mean age: 85.3 years) and 7 women aged 84 to 94 years (mean age: 87.7 years). The PCI group included 10 men aged 71 to 88 years (mean age: 78.8 years) and 8 women aged 77 to 95 years (mean age: 85.6 years). By using quantitative fluorescence RTLs in ZR cells were significantly shorter in the PCI group than in the control group for both men and women ( This study demonstrated ZR cell-specific telomere shortening in patients with adrenal lipid depletion who died after PCI. Our results suggest that the reactive proliferation of ZR cells accelerates the telomere shortening and aging process in ZR cells in these patients. The results of our study may contribute to the understanding of adrenal aging during PCI.
Sections du résumé
Background
The number of patients with prolonged critical illness (PCI) has been increasing in many countries, and the adrenal gland plays an important role in maintaining homeostasis during PCI. Chronic disease burden is reportedly associated with shorter telomere lengths in human tissues. Telomere shortening in human somatic cells is largely dependent on cell divisions, and critically short telomeres lead to cellular dysfunction and aging. However, the association between PCI and telomere lengths in human adrenal cells is poorly understood. In this study, we investigated this association to assess whether the burden of PCI could accelerate the aging process in adrenal cells.
Methods
Adrenocortical tissues from patients who died after PCI usually show a diffuse pattern of intracellular cholesterol ester depletion (i.e., lipid depletion). This study examined near-normal adrenal glands obtained from autopsied patients who died suddenly (control group) and lipid-depleted adrenal glands obtained from autopsied patients who died after PCI (PCI group). The control group included 7 men aged 80 to 94 years (mean age: 85.3 years) and 7 women aged 84 to 94 years (mean age: 87.7 years). The PCI group included 10 men aged 71 to 88 years (mean age: 78.8 years) and 8 women aged 77 to 95 years (mean age: 85.6 years). By using quantitative fluorescence
Results
RTLs in ZR cells were significantly shorter in the PCI group than in the control group for both men and women (
Conclusions
This study demonstrated ZR cell-specific telomere shortening in patients with adrenal lipid depletion who died after PCI. Our results suggest that the reactive proliferation of ZR cells accelerates the telomere shortening and aging process in ZR cells in these patients. The results of our study may contribute to the understanding of adrenal aging during PCI.
Identifiants
pubmed: 37745694
doi: 10.3389/fendo.2023.1244553
pmc: PMC10512174
doi:
Substances chimiques
Cholesterol Esters
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1244553Informations de copyright
Copyright © 2023 Nonaka, Takubo, Aida, Watai, Komatsu, Gomi, Shichi, Yamazaki, Ishiwata, Sasano and Arai.
Déclaration de conflit d'intérêts
YW was employed by Summit Pharmaceuticals International. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Horm Behav. 2017 Mar;89:69-85
pubmed: 27979632
Endocrinology. 2018 Mar 1;159(3):1511-1524
pubmed: 29385420
Biol Lett. 2017 Dec;13(12):
pubmed: 29212750
Crit Care Med. 2015 Feb;43(2):282-7
pubmed: 25377018
Nat Rev Endocrinol. 2019 Jul;15(7):417-427
pubmed: 30850749
Compr Physiol. 2015 Jan;5(1):1-15
pubmed: 25589262
Aging (Albany NY). 2016 Jan;8(1):3-11
pubmed: 26805432
Nat Med. 2006 Oct;12(10):1133-8
pubmed: 17024208
JPEN J Parenter Enteral Nutr. 2019 Feb;43(2):181-193
pubmed: 30288759
J Clin Endocrinol Metab. 2021 Apr 23;106(5):1389-1397
pubmed: 33524149
J Submicrosc Cytol. 1987 Oct;19(4):657-68
pubmed: 3430652
Am J Surg Pathol. 1983 Jan;7(1):29-37
pubmed: 6338750
J Clin Endocrinol Metab. 2016 Dec;101(12):4585-4593
pubmed: 27623070
Scand J Clin Lab Invest. 2002;62(5):361-8
pubmed: 12387582
Eur J Cancer. 2010 Jan;46(2):430-8
pubmed: 19910186
J Pathol. 2010 Jun;221(2):201-9
pubmed: 20455255
Exp Gerontol. 1980;15(2):121-33
pubmed: 7389832
Int J Environ Res Public Health. 2019 Apr 13;16(8):
pubmed: 31013873
Anal Sci. 2022 Jan;38(1):167-173
pubmed: 35287219
Hum Pathol. 2008 Nov;39(11):1647-55
pubmed: 18656239
Crit Care. 2006;10(5):R146
pubmed: 17040563
Mech Ageing Dev. 2019 Jan;177:37-45
pubmed: 29604323
Front Cell Dev Biol. 2021 Apr 01;9:668171
pubmed: 33869233
Int J Mol Sci. 2020 Dec 17;21(24):
pubmed: 33348919
BMC Geriatr. 2020 Jun 9;20(1):200
pubmed: 32517659
Nat Cell Biol. 2022 Feb;24(2):135-147
pubmed: 35165420
Front Endocrinol (Lausanne). 2016 Jun 29;7:82
pubmed: 27445985
J Clin Endocrinol Metab. 2014 Nov;99(11):4214-22
pubmed: 25062464
Crit Care Med. 2021 Jan 1;49(1):70-78
pubmed: 33177360
Nat Rev Endocrinol. 2015 Jan;11(1):14-28
pubmed: 25287283
Science. 1997 Oct 17;278(5337):419-24
pubmed: 9334293
Front Public Health. 2016 Aug 02;4:159
pubmed: 27532034
Science. 2020 Sep 11;369(6509):
pubmed: 32913074
Nat Rev Endocrinol. 2019 Sep;15(9):525-534
pubmed: 31249398
N Engl J Med. 2006 Oct 19;355(16):1647-59
pubmed: 17050889
Endocrinol Metab Clin North Am. 2015 Jun;44(2):243-74
pubmed: 26038200
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009 Apr;27(2):120-39
pubmed: 19412858
Science. 2015 Dec 4;350(6265):1193-8
pubmed: 26785477
Diabetes Care. 2004 Dec;27(12):2893-7
pubmed: 15562203
N Engl J Med. 2013 Apr 18;368(16):1547-9
pubmed: 23506037
Exp Cell Res. 1995 Sep;220(1):194-200
pubmed: 7664836
East Mediterr Health J. 2011 Sep;17(9):665-70
pubmed: 22259916
Hum Cell. 2011 Jun;24(2):96-103
pubmed: 21562774
Cell Mol Neurobiol. 2010 Nov;30(8):1163-70
pubmed: 21080056
Physiol Rev. 1994 Jan;74(1):139-62
pubmed: 8295932
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8167-9
pubmed: 11459947
J Clin Invest. 1965 Jul;44:1234-9
pubmed: 14328399
Nature. 2003 Nov 13;426(6963):194-8
pubmed: 14608368